Search for: "Rachel Sachs" Results 81 - 100 of 126
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2018, 6:44 am by Neil Schoenherr
“Gone are some of President Trump’s older arguments that Medicare should negotiate drug prices, or that drug importation should be permitted more widely,” said Rachel Sachs, associate professor of law in the School of Law. [read post]
7 Dec 2017, 7:27 am by Neil Schoenherr
“Additional testing and approvals are common for expensive on-patent drugs, but we don’t often seek out new uses for less expensive generic drugs, since it can be more difficult to profit from the research,” said Rachel Sachs, associate professor of law. [read post]
9 Oct 2017, 9:09 am by Neil Schoenherr
Sachs“The best-price rule is not as serious a problem as drug manufacturers might perceive it to be,” said Rachel Sachs, associate professor of law and co-author of “Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule,” recently published in the Journal of Health Politics, Policy and Law. [read post]
16 Aug 2017, 7:45 am by Neil Schoenherr
Rachel Sachs, associate professor of law and expert on drug regulation and health law, contributed a chapter on the role that Christian health care sharing ministries play in the health care system. [read post]
3 Aug 2017, 7:30 am by Neil Schoenherr
“One particularly noteworthy dimension of the 21st Century Cures Act was the way in which it originally moved through the House of Representatives,” said Rachel Sachs, associate professor of law. [read post]
12 May 2017, 9:26 am by Diane Toroian Keaggy
Wei Zhu Home: Hunan Province, China Family: Hyunsu Kim, husband Campus life: Board of Trustees graduate student representative, China Law Society vice president On her campus mentors: “I have had many terrific professors, such as Rachel Sachs and Brian Tamanaha. [read post]
5 May 2017, 6:00 am by Doug Cornelius
House Panel Approves Plan to Undo Parts of Dodd-Frank Financial Law by Rachel Witkowski The House Financial Services Committee launched a Republican-supported rollback of Obama-era financial regulations, voting 34-26 along party lines Thursday for a plan to undo significant parts of the 2010 Dodd-Frank law. [read post]
12 Jan 2017, 7:30 am by Neil Schoenherr
Despite announcing in his first press conference that he would deal with a pharmaceutical industry “getting away with murder,” President-elect Donald Trump doesn’t seem to have a clear path for how he will reduce drug prices, said Rachel Sachs, associate professor of law at Washington University in St. [read post]
30 Nov 2016, 1:21 pm by Neil Schoenherr
“One of the most troubling provisions in the previous draft of the bill would’ve created a program for the use of ‘clinical experience’ evidence in drug approvals,” said Rachel Sachs, associate professor of law and an expert on drug regulation and health law. [read post]
1 Oct 2016, 7:07 am by Zachary Burdette
Natan Sachs commented on the accomplishments of the late Shimon Peres. [read post]
31 Aug 2016, 7:02 am by Neil Schoenherr
Sachs“We should not think of ‘price controls’ as a four-letter word,” said Rachel Sachs, associate professor of law and an expert on drug regulation and health law. [read post]
11 Aug 2016, 11:46 am by Jake Linford
Thanks to Rachel Sachs for the following summary of the opening plenary session at IPSC! [read post]
9 Jun 2016, 3:30 am by Amy Monahan
Rachel Sachs, Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, 30 Harv. [read post]
31 May 2016, 4:44 pm by Camilla Alexandra Hrdy
If anyone is looking for a clear and comprehensive review of the ways in which patents can distort investment in innovation, as well as a summary of the literature on incentives "beyond IP", I highly recommend Rachel Sachs' new article Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, forthcoming in the Harvard Journal of Law & Technology. [read post]
22 Jan 2016, 6:19 am by Jim Sedor
The case should prompt a new look at whether the differing treatment of unions and corporations is justified, said Benjamin Sachs, a law professor at Harvard. [read post]
27 Jul 2015, 9:39 am by Lisa Larrimore Ouellette
In Innovation Law and Policy: Preserving the Future of Personalized Medicine, Rachel Sachs (Petrie-Flom Fellow at Harvard Law) examines the intersection of IP with FDA regulation and health law, joining a growing body of scholarship that seeks to contextualize IP in a broader economic context. [read post]
29 May 2015, 3:51 am by Amy Howe
At Bill of Health, Rachel Sachs discusses Tuesday’s opinion in Commil USA v. [read post]
24 Apr 2015, 5:48 am by Thaddeus Mason Pope, J.D., Ph.D.
Sachs, Petrie-Flom Center, Harvard Law School - Religious Exemptions to the Individual Mandate: Health Care Sharing Ministries and the Purposes of the Affordable Care Act Moderator: Marc A. [read post]
12 Apr 2015, 11:00 pm by sbc32
The Petrie-Flom Center, Harvard Law School Rachel E. [read post]
6 Mar 2015, 7:18 am by Amy Howe
”  At Harvard’s Bill of Health Blog, Rachel Sachs notes that “the Court displayed a more sophisticated understanding of the consequences of a decision striking down the subsidies in states that have not established their own exchanges. [read post]